Happiness Biotech Group Limited (NASDAQ: HAPP) is -0.54% lower on its value in year-to-date trading and has touched a low of $1.63 and a high of $6.06 in the current 52-week trading range. The HAPP stock was last observed hovering at around $1.83 in the last trading session, with the day’s gains setting it 0.24% off its average median price target of $10.50 for the next 12 months. It is also 80.29% off the consensus price target high of $10.50 offered by 1 analysts, but current levels are 80.29% higher than the price target low of $10.50 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $2.07, the stock is 14.06% and 13.18% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 23.66 million and changing 12.94% at the moment leaves the stock -11.30% off its SMA200. HAPP registered -58.34% loss for a year compared to 6-month loss of -31.54%. The firm has a 50-day simple moving average (SMA 50) of $1.8472 and a 200-day simple moving average (SMA200) of $2.0764.
The stock witnessed a -2.66% gain in the last 1 month and extending the period to 3 months gives it a -1.08%, and is -0.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.22% over the week and 6.72% over the month.
Happiness Biotech Group Limited (HAPP) has around 179 employees, a market worth around $46.41M and $65.10M in sales. Current P/E ratio is 3.40. Profit margin for the company is 19.50%. Distance from 52-week low is 26.80% and -65.91% from its 52-week high. The company has generated returns on investments over the last 12 months (15.20%).
Happiness Biotech Group Limited (HAPP) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Happiness Biotech Group Limited (HAPP) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Happiness Biotech Group Limited quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to shrink by -34.60% this year.
Happiness Biotech Group Limited (HAPP) Top Institutional Holders
8 institutions hold shares in Happiness Biotech Group Limited (HAPP), with 15.77M shares held by insiders accounting for 63.09% while institutional investors hold 5.44% of the company’s shares. The shares outstanding are 24.69M, and float is at 9.23M with Short Float at 1.33%. Institutions hold 2.01% of the Float.
The top institutional shareholder in the company is Renaissance Technologies, LLC with over 0.26 million shares valued at $0.46 million. The investor’s holdings represent 1.01% of the HAPP Shares outstanding. As of Sep 29, 2020, the second largest holder is Acadian Asset Management with 88966.0 shares valued at $0.16 million to account for 0.34% of the shares outstanding. The other top investors are Marshall Wace LLP which holds 78919.0 shares representing 0.30% and valued at over $0.14 million, while HRT Financial LLC holds 0.18% of the shares totaling 46551.0 with a market value of $82395.0.